Here's what you missed during the holiday break

Welcome back after a nice holiday breather, and Happy New Year to all.

While many were on holiday break this last week or so, the device and diagnostics industries were anything but quiet.

St. Jude Medical ($STJ), for example, buried the hatchet with a supplier of Durata leads. Covidien ($COV) snatched up a startup focused on developing peripheral artery disease treatment technology. And the FDA was--to say the least--really busy.

Below are links to those and other stories you might have missed:

> FDA says Zimmer's recalled tool could be deadly

> FDA action forces Invacare layoffs

> GE recalls infant resuscitation circuits as FDA warns of fatal risk

> Covidien grabs CA startup for PAD treatment tech

> St. Jude buries the hatchet with Durata supplier

> Device companies soldier on against the device tax even as change window closes

-- Mark Hollmer (email | Twitter)

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.